Arun V J: Don’t Miss TRANSCON 2026 – A Direct Pathway Into India’s Clinical and Institutional Network
Arun V J, The Leader of Transfusion Medicine at Malabar Medical College, shared a post on LinkedIn:
”If you’re in Blood Banking, Transfusion Medicine, MedTech, IVD, diagnostics, or healthcare marketing, India is no longer a ‘next’ market – it’s a current growth priority.
With one of the fastest-expanding healthcare ecosystems globally, the real question is not if you enter – but how effectively you engage the right stakeholders.
Welcome to India’s largest gathering of Blood Banking/Transfusion Medicine Professionals.
TRANSCON 2026 (18–20 September | Kochi, India) is designed for exactly that.
It brings together:
- Clinicians and transfusion specialists
- Policy influencers and program leaders
- Hospital decision-makers and academic experts
- Industry partners across blood banking, diagnostics, and advanced therapies
This is not a conventional conference or passive exhibition.
It is a working interface where:
- technologies are critically evaluated – not just displayed
- procurement pathways and collaborations begin
- market understanding moves from theory to real conversations
With 1000+ delegates and 100+ national and international faculty, the engagement is both high-density and decision-focused.
If your organisation is working in:
- Blood Banking and Transfusion Medicine
- Apheresis and Cellular Therapies
- Diagnostics and Immunohematology
- AI, Automation and Digital Health
- Plasma, Fractionation and Biologics
This platform offers a direct pathway into India’s clinical and institutional network.
The attached brochure outlines:
- Scientific tracks and emerging themes
- Pre-conference workshops (AI, apheresis, transplant immunology, regenerative medicine)
- Industry engagement opportunities
India is scaling rapidly across healthcare delivery, infrastructure, and technology adoption.
TRANSCON 2026 is where global innovation meets this scale.
If India is part of your strategic roadmap, this is a high-value touchpoint.”
Stay updated with Hemostasis Today.
-
Jun 9, 2026, 10:37Maria Bruzelius: Hemophilia and Bleeding Disorder in Clinical Practice at NordCoag 2026
-
Jun 9, 2026, 10:02Understanding Factor X Deficiency – ICHCC
-
Jun 9, 2026, 09:49Lee Severin: Why Patients Love Platelet-Rich Plasma
-
Jun 9, 2026, 09:42Lorena Gerlach: Blood Transportation Duty on this Muggy Spring Day
-
Jun 9, 2026, 08:54Shujha Abbas: Understanding the Real Cost of Gene Therapie
-
Jun 9, 2026, 04:47Akshat Jain: Marstacimab Gets FDA Expension for Children with Hemophilia B
-
Jun 9, 2026, 03:30Fayad Al-Haimus: High-Risk Emergencies and Lifelong Learning at CAEP 2026
-
Jun 9, 2026, 03:14Rucha Patil: A Collaborative Initiative to Transform Rare Blood Disorder Care in Rajasthan
-
Jun 9, 2026, 02:28Andreas Calatzis: Chasing Biologically Inactive Heparin?